This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2007 Apr 24;68(17):1428-9.

doi: 10.1212/01.wnl.0000264017.08217.39.

Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy

B H Elsheikh¹, E Bollman, M Peruggia, W King, G Galloway, J T Kissel

Affiliations

PMID: 17452589
DOI: 10.1212/01.wnl.0000264017.08217.39

Clinical Trial

Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy

B H Elsheikh et al. Neurology. 2007.

. 2007 Apr 24;68(17):1428-9.

doi: 10.1212/01.wnl.0000264017.08217.39.

Authors

B H Elsheikh¹, E Bollman, M Peruggia, W King, G Galloway, J T Kissel

Affiliation

¹ Department of Neurology, The Ohio State University, Columbus, OH 43210, USA.

PMID: 17452589
DOI: 10.1212/01.wnl.0000264017.08217.39

No abstract available

PubMed Disclaimer

Similar articles

The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD).
Skalsky AJ, Abresch RT, Han JJ, Shin CS, McDonald CM. Skalsky AJ, et al. Neuromuscul Disord. 2008 Nov;18(11):873-80. doi: 10.1016/j.nmd.2008.07.005. Epub 2008 Sep 24. Neuromuscul Disord. 2008. PMID: 18818077
Fascioscapulohumeral muscular dystrophy: a progressive degenerative disease that responds to diltiazem.
Lefkowitz DL, Lefkowitz SS. Lefkowitz DL, et al. Med Hypotheses. 2005;65(4):716-21. doi: 10.1016/j.mehy.2005.04.035. Med Hypotheses. 2005. PMID: 15963657
Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength.
Skalsky AJ, Han JJ, Abresch RT, Shin CS, McDonald CM. Skalsky AJ, et al. Muscle Nerve. 2009 May;39(5):647-51. doi: 10.1002/mus.21212. Muscle Nerve. 2009. PMID: 19347922
Diltiazem-induced photodistributed hyperpigmentation.
Boyer M, Katta R, Markus R. Boyer M, et al. Dermatol Online J. 2003 Dec;9(5):10. Dermatol Online J. 2003. PMID: 14996383 Review.
[Diltiazem in acute coronary syndromes].
Fedele F, Cacciotti L, Di Donato D, Addonisio L, Musarò S, Lavalle C. Fedele F, et al. Cardiologia. 1999 Dec;44 Suppl 1(Pt 1):319-22. Cardiologia. 1999. PMID: 12497928 Review. Italian. No abstract available.

See all similar articles

Cited by

MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy.
Runfola V, Giambruno R, Caronni C, Pannese M, Andolfo A, Gabellini D. Runfola V, et al. Cell Rep. 2023 Sep 26;42(9):113120. doi: 10.1016/j.celrep.2023.113120. Epub 2023 Sep 12. Cell Rep. 2023. PMID: 37703175 Free PMC article.
Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.
Hamel J, Tawil R. Hamel J, et al. Neurotherapeutics. 2018 Oct;15(4):863-871. doi: 10.1007/s13311-018-00675-3. Neurotherapeutics. 2018. PMID: 30361930 Free PMC article. Review.
Calcium antagonists for Duchenne muscular dystrophy.
Phillips MF, Quinlivan R. Phillips MF, et al. Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD004571. doi: 10.1002/14651858.CD004571.pub2. Cochrane Database Syst Rev. 2008. PMID: 18843663 Free PMC article.
[Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].
Jordan B, Müller-Reible C, Zierz S. Jordan B, et al. Nervenarzt. 2011 Jun;82(6):712-22. doi: 10.1007/s00115-010-2968-x. Nervenarzt. 2011. PMID: 21567298 German.
Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle.
Campbell AE, Belleville AE, Resnick R, Shadle SC, Tapscott SJ. Campbell AE, et al. Hum Mol Genet. 2018 Aug 1;27(R2):R153-R162. doi: 10.1093/hmg/ddy162. Hum Mol Genet. 2018. PMID: 29718206 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

M01-RR00034/RR/NCRR NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database